Your browser doesn't support javascript.
The potential public health consequences of COVID-19 on malaria in Africa.
Sherrard-Smith, Ellie; Hogan, Alexandra B; Hamlet, Arran; Watson, Oliver J; Whittaker, Charlie; Winskill, Peter; Ali, Fatima; Mohammad, Audu B; Uhomoibhi, Perpetua; Maikore, Ibrahim; Ogbulafor, Nnenna; Nikau, Jamilu; Kont, Mara D; Challenger, Joseph D; Verity, Robert; Lambert, Ben; Cairns, Matthew; Rao, Bhargavi; Baguelin, Marc; Whittles, Lilith K; Lees, John A; Bhatia, Sangeeta; Knock, Edward S; Okell, Lucy; Slater, Hannah C; Ghani, Azra C; Walker, Patrick G T; Okoko, Okefu Oyale; Churcher, Thomas S.
  • Sherrard-Smith E; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Hogan AB; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Hamlet A; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Watson OJ; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Whittaker C; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Winskill P; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Ali F; National Malaria Elimination Programme, Abuja, Nigeria.
  • Mohammad AB; National Malaria Elimination Programme, Abuja, Nigeria.
  • Uhomoibhi P; National Malaria Elimination Programme, Abuja, Nigeria.
  • Maikore I; National Malaria Elimination Programme, Abuja, Nigeria.
  • Ogbulafor N; National Malaria Elimination Programme, Abuja, Nigeria.
  • Nikau J; National Malaria Elimination Programme, Abuja, Nigeria.
  • Kont MD; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Challenger JD; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Verity R; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Lambert B; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Cairns M; Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
  • Rao B; Manson Unit, Médecins Sans Frontières (Operational Centre Amsterdam), London, UK.
  • Baguelin M; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Whittles LK; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Lees JA; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Bhatia S; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Knock ES; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Okell L; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Slater HC; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Ghani AC; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Walker PGT; PATH, Seattle, WA, USA.
  • Okoko OO; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Churcher TS; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Nat Med ; 26(9): 1411-1416, 2020 09.
Article in English | MEDLINE | ID: covidwho-707103
ABSTRACT
The burden of malaria is heavily concentrated in sub-Saharan Africa (SSA) where cases and deaths associated with COVID-19 are rising1. In response, countries are implementing societal measures aimed at curtailing transmission of SARS-CoV-22,3. Despite these measures, the COVID-19 epidemic could still result in millions of deaths as local health facilities become overwhelmed4. Advances in malaria control this century have been largely due to distribution of long-lasting insecticidal nets (LLINs)5, with many SSA countries having planned campaigns for 2020. In the present study, we use COVID-19 and malaria transmission models to estimate the impact of disruption of malaria prevention activities and other core health services under four different COVID-19 epidemic scenarios. If activities are halted, the malaria burden in 2020 could be more than double that of 2019. In Nigeria alone, reducing case management for 6 months and delaying LLIN campaigns could result in 81,000 (44,000-119,000) additional deaths. Mitigating these negative impacts is achievable, and LLIN distributions in particular should be prioritized alongside access to antimalarial treatments to prevent substantial malaria epidemics.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Malaria / Antimalarials Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2020 Document Type: Article Affiliation country: S41591-020-1025-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Malaria / Antimalarials Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2020 Document Type: Article Affiliation country: S41591-020-1025-y